SmartNuclide

SmartNuclide

智核生物

SmartNuclide

Biotech/Healthcare

Founded in 2015, Suzhou SmartNuclide Biopharmaceutical Technology Co., Ltd. is a new drug R&D company dedicated to tumor diagnosis and treatment using recombinant protein radiopharmaceuticals.

Latest round: Series D (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-09-14

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.